Cargando…

Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy

Objective. Encephalopathy and brain edema are serious complications of acute liver injury and may lead to rapid death of patients. The present study was designed to investigate the role of the inflammatory mediators and oxidative stress in the cytotoxic brain oedema and the neuroprotective effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamal, Maha, Abdel Wahab, Zainab, Eshra, Mohamed, Rashed, Laila, Sharawy, Nivin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945529/
https://www.ncbi.nlm.nih.gov/pubmed/24693424
http://dx.doi.org/10.1155/2014/254683
_version_ 1782306533754798080
author Gamal, Maha
Abdel Wahab, Zainab
Eshra, Mohamed
Rashed, Laila
Sharawy, Nivin
author_facet Gamal, Maha
Abdel Wahab, Zainab
Eshra, Mohamed
Rashed, Laila
Sharawy, Nivin
author_sort Gamal, Maha
collection PubMed
description Objective. Encephalopathy and brain edema are serious complications of acute liver injury and may lead to rapid death of patients. The present study was designed to investigate the role of the inflammatory mediators and oxidative stress in the cytotoxic brain oedema and the neuroprotective effects of both minocycline and dexamethasone. Methods. 48 male albino rats were divided into 4 groups: control group, acute liver injury (ALI) group, minocycline pretreated ALI group, and dexamethasone pretreated ALI group. 24 hours after acute liver injury serum ammonia, liver enzymes, brain levels of heme oxygenase-1 gene, iNOS gene expression, nitrite/nitrate, and cytokines were measured. In addition, the grades of encephalopathy and brain water content were assessed. Results. ALI was associated with significant increases in all measured inflammatory mediators, oxidative stress, iNOS gene expression, and nitrite/nitrate. Both minocycline and dexamethasone significantly modulated the inflammatory changes and the oxidative/nitrosative stress associated with ALI. However, only minocycline but not dexamethasone significantly reduced the cytotoxic brain oedema. Conclusion. Both minocycline and dexamethasone could modulate inflammatory and oxidative changes observed in brain after ALI and could be novel preventative therapy for hepatic encephalopathy episodes.
format Online
Article
Text
id pubmed-3945529
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39455292014-04-01 Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy Gamal, Maha Abdel Wahab, Zainab Eshra, Mohamed Rashed, Laila Sharawy, Nivin Neurol Res Int Research Article Objective. Encephalopathy and brain edema are serious complications of acute liver injury and may lead to rapid death of patients. The present study was designed to investigate the role of the inflammatory mediators and oxidative stress in the cytotoxic brain oedema and the neuroprotective effects of both minocycline and dexamethasone. Methods. 48 male albino rats were divided into 4 groups: control group, acute liver injury (ALI) group, minocycline pretreated ALI group, and dexamethasone pretreated ALI group. 24 hours after acute liver injury serum ammonia, liver enzymes, brain levels of heme oxygenase-1 gene, iNOS gene expression, nitrite/nitrate, and cytokines were measured. In addition, the grades of encephalopathy and brain water content were assessed. Results. ALI was associated with significant increases in all measured inflammatory mediators, oxidative stress, iNOS gene expression, and nitrite/nitrate. Both minocycline and dexamethasone significantly modulated the inflammatory changes and the oxidative/nitrosative stress associated with ALI. However, only minocycline but not dexamethasone significantly reduced the cytotoxic brain oedema. Conclusion. Both minocycline and dexamethasone could modulate inflammatory and oxidative changes observed in brain after ALI and could be novel preventative therapy for hepatic encephalopathy episodes. Hindawi Publishing Corporation 2014 2014-02-17 /pmc/articles/PMC3945529/ /pubmed/24693424 http://dx.doi.org/10.1155/2014/254683 Text en Copyright © 2014 Maha Gamal et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gamal, Maha
Abdel Wahab, Zainab
Eshra, Mohamed
Rashed, Laila
Sharawy, Nivin
Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy
title Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy
title_full Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy
title_fullStr Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy
title_full_unstemmed Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy
title_short Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy
title_sort comparative neuroprotective effects of dexamethasone and minocycline during hepatic encephalopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945529/
https://www.ncbi.nlm.nih.gov/pubmed/24693424
http://dx.doi.org/10.1155/2014/254683
work_keys_str_mv AT gamalmaha comparativeneuroprotectiveeffectsofdexamethasoneandminocyclineduringhepaticencephalopathy
AT abdelwahabzainab comparativeneuroprotectiveeffectsofdexamethasoneandminocyclineduringhepaticencephalopathy
AT eshramohamed comparativeneuroprotectiveeffectsofdexamethasoneandminocyclineduringhepaticencephalopathy
AT rashedlaila comparativeneuroprotectiveeffectsofdexamethasoneandminocyclineduringhepaticencephalopathy
AT sharawynivin comparativeneuroprotectiveeffectsofdexamethasoneandminocyclineduringhepaticencephalopathy